Millions of books in English, Spanish and other languages. Free UK delivery 

menu

0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional
portada Interface Between Regulation and Statistics in Drug Development (Chapman & Hall
Type
Physical Book
Year
2020
Language
English
Pages
172
Format
Hardcover
ISBN13
9780367490485
Edition No.
1

Interface Between Regulation and Statistics in Drug Development (Chapman & Hall

Demissie Alemayehu; Birol Emir; Michael Gaffney (Author) · · Hardcover

Interface Between Regulation and Statistics in Drug Development (Chapman & Hall - Demissie Alemayehu; Birol Emir; Michael Gaffney

Physical Book

£ 108.00

£ 120.00

You save: £ 12.00

10% discount
  • Condition: New
It will be shipped from our warehouse between Wednesday, July 17 and Monday, July 22.
You will receive it anywhere in United Kingdom between 1 and 3 business days after shipment.

Synopsis "Interface Between Regulation and Statistics in Drug Development (Chapman & Hall"

With the critical role of statistics in the design, conduct, analysis and reporting of clinical trials or observational studies intended for regulatory purposes, numerous guidelines have been issued by regulatory authorities around the world focusing on statistical issues related to drug development. However, the available literature on this important topic is sporadic, and often not readily accessible to drug developers or regulatory personnel. This book provides a systematic exposition of the interplay between the two disciplines, including emerging themes pertaining to the acceleration of the development of pharmaceutical medicines to serve patients with unmet needs. Features: Regulatory and statistical interactions throughout the drug development continuum The critical role of the statistician in relation to the changing regulatory and healthcare landscapes Statistical issues that commonly arise in the course of drug development and regulatory interactions Trending topics in drug development, with emphasis on current regulatory thinking and the associated challenges and opportunities The book is designed to be accessible to readers with an intermediate knowledge of statistics, and can be a useful resource to statisticians, medical researchers, and regulatory personnel in drug development, as well as graduate students in the health sciences. The authors' decades of experience in the pharmaceutical industry and academia, and extensive regulatory experience, comes through in the many examples throughout the book.

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

All books in our catalog are Original.
The book is written in English.
The binding of this edition is Hardcover.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews